CPT® Code 90748

1. Indications

The Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB) is indicated for the following:

• Protection Against Hepatitis B: The vaccine is administered to provide long-term immunity against hepatitis B, a serious liver disease that can lead to chronic infection, liver cirrhosis, and hepatocellular carcinoma.
• Protection Against Haemophilus influenzae type b: It is indicated for the prevention of infections caused by Hib, particularly in children under the age of five, who are at a higher risk for severe complications such as pneumonia, meningitis, and other invasive diseases.

2. Procedure

The administration of the Hib-HepB vaccine involves several key procedural steps:

• Step 1: Preparation of the Vaccine The vaccine is prepared according to the manufacturer's guidelines, ensuring that it is stored at the appropriate temperature and is not expired. The healthcare provider must inspect the vaccine for any particulate matter or discoloration before use.
• Step 2: Patient Assessment Prior to administration, the healthcare provider should assess the patient’s medical history, including any previous allergic reactions to vaccines, current health status, and any contraindications to vaccination.
• Step 3: Site Selection The vaccine is administered intramuscularly, typically in the deltoid muscle of the upper arm for older children and adults, or in the anterolateral thigh for infants and young children. The site should be cleaned with an antiseptic wipe to reduce the risk of infection.
• Step 4: Administration of the Vaccine Using a sterile syringe and needle, the healthcare provider injects the vaccine into the selected muscle site. The injection should be performed swiftly and smoothly to minimize discomfort.
• Step 5: Post-Administration Care After the vaccine is administered, the healthcare provider should observe the patient for a brief period to monitor for any immediate adverse reactions. The patient or guardian should be informed about potential side effects and the importance of follow-up doses if applicable.

3. Post-Procedure

Post-procedure care for the Hib-HepB vaccine includes monitoring the patient for any immediate adverse reactions, such as allergic responses or injection site reactions. Patients may experience mild side effects, including soreness at the injection site, low-grade fever, or irritability, which typically resolve within a few days. It is important to provide the patient or guardian with information regarding these potential side effects and to advise them on when to seek medical attention. Additionally, if the vaccine is part of a multi-dose series, the healthcare provider should schedule follow-up appointments to ensure the completion of the vaccination series for optimal immunity.